BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stec DE, Hinds TD Jr. Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E9493. [PMID: 33327438 DOI: 10.3390/ijms21249493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sorrenti V, D'Amico AG, Barbagallo I, Consoli V, Grosso S, Vanella L. Tin Mesoporphyrin Selectively Reduces Non-Small-Cell Lung Cancer Cell Line A549 Proliferation by Interfering with Heme Oxygenase and Glutathione Systems. Biomolecules 2021;11:917. [PMID: 34205698 DOI: 10.3390/biom11060917] [Reference Citation Analysis]
2 Stec DE, Abraham NG. Pharmacological and Clinical Significance of Heme Oxygenase-1. Antioxidants (Basel) 2021;10:854. [PMID: 34071751 DOI: 10.3390/antiox10060854] [Reference Citation Analysis]
3 Zehfus LR, Gillespie ZE, Almendáriz-Palacios C, Low NH, Eskiw CH. Haskap Berry Phenolic Subclasses Differentially Impact Cellular Stress Sensing in Primary and Immortalized Dermal Fibroblasts. Cells 2021;10:2643. [PMID: 34685623 DOI: 10.3390/cells10102643] [Reference Citation Analysis]
4 Ryter SW. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants 2022;11:555. [DOI: 10.3390/antiox11030555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Guo C, Zhang C, Xia Z, Song B, Hu W, Cui Y, Xue Y, Xia M, Xu D, Zhang S, Fang J. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation. J Control Release 2021;341:566-77. [PMID: 34864115 DOI: 10.1016/j.jconrel.2021.11.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Creeden JF, Kipp ZA, Xu M, Flight RM, Moseley HNB, Martinez GJ, Lee WH, Alganem K, Imami AS, McMullen MR, Roychowdhury S, Nawabi AM, Hipp JA, Softic S, Weinman SA, McCullumsmith R, Nagy LE, Hinds TD Jr. Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. Hepatology 2022. [PMID: 35313030 DOI: 10.1002/hep.32467] [Reference Citation Analysis]
7 Vítek L. The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders. Antioxid Redox Signal 2021. [PMID: 33906434 DOI: 10.1089/ars.2021.0080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Consoli V, Sorrenti V, Grosso S, Vanella L. Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions. Biomolecules 2021;11:589. [PMID: 33923744 DOI: 10.3390/biom11040589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Liang C, Yu Z, Bai L, Hou W, Tang S, Zhang W, Chen X, Hu Z, Duan Z, Zheng S. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Front Endocrinol 2022;13:869579. [DOI: 10.3389/fendo.2022.869579] [Reference Citation Analysis]
10 Stec DE, Wegiel B, Hinds TD Jr. Editorial: Oxidative Stress, Antioxidants, Transcription Factors, and Assimilation of Signal Transduction Pathways in Obesity-Related Disorders. Front Pharmacol 2021;12:759468. [PMID: 34557106 DOI: 10.3389/fphar.2021.759468] [Reference Citation Analysis]
11 Gordon DM, Hong SH, Kipp ZA, Hinds TD Jr. Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha). Molecules 2021;26:2975. [PMID: 34067839 DOI: 10.3390/molecules26102975] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Thomas DT, Delcimmuto NR, Flack KD, Stec DE, Hinds TD. Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Antioxidants 2022;11:179. [DOI: 10.3390/antiox11020179] [Reference Citation Analysis]